Sepsis and Septic Shock

Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Log in to access
Last updated: May 28, 2026Bookmark

Sepsis is a life-threatening condition caused by a dysregulated immune response to pathogens or their toxins in blood or tissue. The organisms can be bacteria, viruses or fungi, while toxins may include endotoxin (LPS) or exotoxins.

Sepsis may range from mild e.g. cellulitis to severe e.g. septic shock +/- organ dysfunction. It exists as a continuum: Infection → systemic Inflammatory Response (SIRS) → sepsis → severe sepsis or organ dysfunction → septic shock → multi-organ dysfunction syndrome (MODS)

The overall mortality from sepsis is 25%

Definition of terms

TermDefinition
Septic shockPersistent hypotension despite fluid resuscitation, requiring vasopressors to keep MAP ≥ 65 mmHg, and a serum lactate level of > 2 mmol/l
BacteraemiaPresence of bacteria in the blood stream
SepticaemiaPresence of large numbers of actively dividing bacteria in the blood stream resulting in systemic inflammatory response (SIRS) leading to organ dysfunciton
PyaemiaSepticaemia caused by pus-forming bacteria e.g. staphylococci
Systemic inflamamtory response syndrome (SIRS)Systemic inflammatory response characterized by two or more of: hyperthermia, tachycardia, tachypnoea, neutrophilia or neutropaenia. Mediated pro-inflamamtory by IL-1, TNF-a, IL-6, IL-8, IF-Y which activate coagulation cascade (microvascular thrombosis), complement cascade (vascular permiability), and endothelial damage.
Counter inflammatory response syndrome (CARS)Systemic response that antagonizes SIRS through the action of IL-4 and IL-10.

Sepsis-3 now defines sepsis as suspected or confirmed infection plus organ dysfunction, represented by an increase in SOFA score ≥ 2 points

Sequential Organ Failure Assessment (SOFA) score: evaluates 6 organ systems (each scored from 0 – 4). A score ≥ 2 points suggests significant organ dysfunction.

Organ SystemParameter
RespiratoryPaO₂/FiO₂ ratio
CoagulationPlatelet count
LiverBilirubin
CardiovascularMAP and vasopressor requirement
CNSGlasgow Coma Scale
RenalCreatinine or urine output

Detailed SOFA Score

SystemScore 0Score 1Score 2Score 3Score 4
PaO2 /FI O2>400<400<300<200<100
Platelets x103microlitres>150<150<100<50<20
Bilirubin µmol/L2020-3233-101102-204>204
CardiovascularMAP >70mmHgMAP 70mmHgDopamine <5 or dobutamine (any dose)Dopamine 5.1-15or epinephrine 0.1or norepinephrine 0.1Dopamine >15 orepinephrine >0.1or norepinephrine >0.1
GCS1513-1410-126-9<6
Creatinine µmol/L<110110-170171-299300-440>440
Urine output ml/day>500>500>500<500<200

Quick Sequential Organ Failure Assessment (qSOFA): a simplified bedside screening tool outisde the ICU to rapidly identify patients who need urgent evaluation. A qSOFA ≥ 2 is associated with poor outcomes.

  • Respiratory rate > 22/min
  • Altered mentation (GCS < 15)
  • Systolic blood pressure < 100 mmHg
  • Common causes of systemic inflammatory response syndrome (SIRS)
  • Risk factors
    • Diabetes
    • Cancer
    • Chronic kidney disease
    • Liver disease
    • Immunosuppression
    • Steroid use
    • Burns
    • Trauma
    • Indwelling catheters
    • Extremes of age
  • Pathophysiology
    • Pathogen virulence → survival, replication, and dissemination within the body
    • Pathogen-associated molecular patterns (PAMPs) are recognized by Toll-like receptors (TLRs) → immune activation and release of pro-inflammatory cytokines
    • Immune activation by pathogens → Systemic inflammatory response syndrome (SIRS)
      • Endothelial injury → capillary leak → oedema and hypovolemia
      • Vasodilation → low systemic vascular resistance and hypotension
      • Microvascular thrombosis → worsened tissue perfusion
      • Tissue hypoxia → lactate accumulates
    • Immunoparalysis
      • Compensatory anti-inflammatory response (CARS) suppresses the immune system making septic patients susceptible to secondary infections
    • Organ dysfunction
      • Lungs → acute respiratory distress syndrome (ARDS)
      • Kidneys → acute kidney injury (AKI)
      • Brain → encephalopathy
      • Liver → hepatic dysfunction
      • Cardiovascular system → shock
  • Signs and sysmptoms
    • Early
    • Severe
      • Altered mental status
      • Oliguria
      • Hypoxia
      • Cyanosis
      • Elevated lactate
    • Warm septic shock (early)
      • Warm extremities
      • Bounding pulses
      • Flash capillary refill
      • Tachycardia
    • Cold septic shock (late)
      • Hypotension
      • Cool extremities
      • Delayed capillary refill time
      • Weak pulses
  • Investigations
    • Complete blood count and peripheral blood film
      • Leukocytosis or leukopenia
      • Thrombocytopaenia
      • Bandemia
    • CRP and procalcitonin
      • Elevated
    • Lactate
      • 2 mmol/L
      • 4 mmol/L correlates with worse tissue hypoperfusion and mortality
    • Coagulation panel
      • Elevated INR
      • Elevated aPTT
    • Liver function test
      • Hyperbilirubinaemia
    • Renal function test
    • Blood gas analysis
    • Blood cultures
    • Urinalysis
    • Chest X-ray
    • CT imaging if indicated
  • Initial treatment
    • The sepsis six bundle should be administered within 1 hour
    1. Administer oxygen
      • Aim to keep saturation > 94% or 88-92% in COPD
    2. Blood cultures
    3. Broad spectrum antibiotics
      • Within 1 hour
      • Target the likely organism
    4. Intravenous fluid challenge
      • 30 ml/kg crystalloid bolus or 500 ml crystalloid over less than 15 minutes
      • For hypotension or lactate > 4 mmol/L
      • Vasopressors if hypotension persists after fluids
      • Target MAP ≥ 65 mmHg
    5. Measure serum lactate
    6. Measure urine output hourly
  • Further treatment
    • Source control
      • Drain abscesses
      • Remove infected lines or devices
      • Debride necrotic tissues
    • Organ support
      • Mechanical ventilation for ARDS
      • Dialysis for renal failure
      • Nutritional support
      • DVT prophylaxis
      • Stress ulcer prophylaxis
  • Complications
    • Acute respiratory distress syndrome
    • Disseminateed intravascular coagulation
    • Acute kidney injury
    • Liver failure
    • Mesenteric ischaemia
    • Myocardial dysfunction
    • Multi-organ failure

Surviving Sepsis Bundles

Bundle StageInterventionKey Details / TargetsPurpose
Initial / Hour-1 BundleMeasure lactateLactate >2 mmol/L suggests hypoperfusionAssess severity and prognosis
Obtain blood culturesAt least 2 sets before antibiotics if possibleIdentify causative organism
Start broad-spectrum antibioticsIdeally within 1 hourReduce mortality from delayed treatment
Fluid resuscitation30 ml/kg crystalloidRestore intravascular volume and tissue perfusion
Vasopressors if hypotensive after fluidsFirst-line: norepinephrineMaintain organ perfusion
Blood pressure targetMAP > 65 mmHgAdequate tissue perfusion
Reassessment BundleRepeat lactateIf initially elevatedMonitor response to therapy
Reassess perfusionHR, BP, urine output, capillary refill, mental stateGuide ongoing management
24-Hour Management BundleSource controlDrain abscess, remove infected devices, surgery if neededEliminate infection source
Lung-protective ventilation6 ml/kg tidal volumeReduce ventilator-induced lung injury in Acute respiratory distress syndrome
Glucose controlMaintain glucose <180 mg/dLPrevent complications of hyperglycemia
CorticosteroidsHydrocortisone for refractory shockImprove vasopressor responsiveness
DVT prophylaxisAnticoagulation/mechanical methodsPrevent thromboembolism
Stress ulcer prophylaxisPPIs/H2 blockers if indicatedPrevent GI bleeding
Early enteral feedingPrefer enteral over parenteral nutritionPreserve gut integrity and reduce bacterial translocation
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team